MARKET

AVTX

AVTX

Avalo Therapeutics Inc
NASDAQ
0.1207
-0.0207
-14.64%
Pre Market: 0.1257 +0.005 +4.14% 06:23 10/02 EDT
OPEN
0.1412
PREV CLOSE
0.1414
HIGH
0.1465
LOW
0.1200
VOLUME
407.89K
TURNOVER
--
52 WEEK HIGH
7.00
52 WEEK LOW
0.0806
MARKET CAP
17.75M
P/E (TTM)
-0.0565
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at AVTX last week (0925-0929)?
Weekly Report · 54m ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 3d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 3d ago
Why Galecto Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Benzinga · 4d ago
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga · 5d ago
Avalo Therapeutics eliminates $35m debt owed to Horizon Technology Finance
Seeking Alpha · 5d ago
Why Avalo Therapeutics Stock Is Up Today
Benzinga · 5d ago
Why Femasys Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket
Benzinga · 5d ago
More
About AVTX
Avalo Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on the treatment of immune dysregulation by developing therapies that target the Lymphotoxin-like, exhibits Inducible expression, and competes with Herpes Virus Glycoprotein D for Herpesvirus Entry Mediator (HVEM), a receptor expressed by T lymphocytes (LIGHT)-signaling network. Its clinical-stage pipeline includes AVTX-002, AVTX-008, and AVTX-803 programs. AVTX-002 is an Anti-LIGHT monoclonal antibody for treatment of non-eosinophilic asthma, Crohn’s Disease, and COVID-19 acute respiratory distress syndromes. AVTX-008 is a fully human B and T lymphocyte attenuator (BTLA) agonist fusion protein that is being evaluated for several immune dysregulation disorders. AVTX-803 is a monosaccharide therapy for the treatment of leukocyte adhesion deficiency type II (LAD II), which is a congenital disorder of glycosylation (CDG).

Webull offers kinds of Avalo Therapeutics Inc stock information, including NASDAQ:AVTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVTX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AVTX stock methods without spending real money on the virtual paper trading platform.